BlueNalu looks to commercialize cell-based seafood with $60 million funding

January 22, 2021
CPG More...
“Better-for-You” Transformation More...
Very important

Led by Rage Capital, this convertible note financing will help BlueNalu realize its commercialization plans, including the completion of a 40,000 ft2 pilot facility in the U.S. This funding round also places BlueNalu as the front-runner in the cell-based seafood space. The company's first product is a cell-based mahi-mahi fillet, followed by premium blue fin tuna. With strategic partnerships with Asian players like Pulmuone under its belt, BlueNalu is also eyeing Asia as a key market for cell-based seafood. Clients, the cell-based meat and seafood space is witnessing unprecedented growth, and this momentum will carry forward going into 2021. Now is the time to engage either through investments or through strategic partnerships.

For the original news article, click here .

Further Reading

Shiok Meats expands its product offerings through Gaia Foods acquisition

News Commentary | August 19, 2021

The deal amount was not disclosed, but Gaia Foods, which is working on cell‑based structured red meat (beef and pork) production, will now be a part of fellow Singaporean startup Shiok Meats. This acquisition complements Shiok's existing expertise in cell‑based seafood, with a focus on shrimp ... Not part of subscription

ChickP names new CEO and nets USD 8 million in Series A

News Commentary | February 01, 2022

Israeli startup ChickP has completed a USD 8 million Series A funding round led by Genisys Capital and strategic partner Growthwell Foods, bringing ChickP's total funding to USD 10 million. New funding will be used to expand the commercialization of its IP‑protected extraction process to produce ... Not part of subscription

Upside Foods raises a whopping USD 400 million in funding as it looks to commercialize cell-based meat production in the U.S.

News Commentary | April 29, 2022

Co‑led by Temasek and the Abu Dhabi Growth Fund, with participation from several strategic investors like Cargill and Givaudan, this Series C funding round is the biggest ever in the cell‑based meat space, eclipsing Future Meat’s recent financing of USD 347 million. The company will use this cash ... Not part of subscription